Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: donpat who wrote (10876)	8/17/2018 12:56:59 PM
From: HardToFind	Read Replies (1) \| Respond to of 12873

Do the 'Cides Work? I have every confidence that the 'cides have been made to work for both herpes (HSV-1, HSV-2, VZA) and the flu. Granted, not every drug candidate that the company has tested has worked, and not every viricide pursued was successful, but that's the nature of research. For instance, it is not at all clear that any of their attempts at ebola worked. But I think Zika and West Nile would not be that hard to make happen (due to their similarity to other viruses within reach) if they only had the money and focus left to pursue them. But it appears they are lacking in both today just in pursuing the monetization of drugs for herpes and the flu. I'm convinced that the company definitely has found drug candidates that work, and there is a very high probability that they will work in humans both safely and effectively. The concerns are more along the lines of the profits and losses due to production and licensing expenses and issues. It would also be nice to see a management team that demonstrates they have the common shareholders' interests in mind and can execute a business plan to a schedule that works for the shareholders.